Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease

Clinica Chimica Acta

Volumn 341, Issue 1-2, 2004, Pages 41-48

  Mueller, Thomas ^a   Gegenhuber, Alfons ^a   Poelz, Werner ^b   Haltmayer, Meinhard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

Author keywords

Diagnosis; Echocardiography; Heart failure; Natriuretic peptides

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; AUTOANALYSIS; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HEART DISEASE; HEART FAILURE; HUMAN; INTERMETHOD COMPARISON; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ROC CURVE; STATISTICAL SIGNIFICANCE; SYMPTOM;

EID: 1142273248     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.10.027     Document Type: Article

References (24)

1. Hammerer-Lercher A., Puschendorf B., Mair J. Cardiac natriuretic peptides: new laboratory parameters in heart failure patients. Clin. Lab. 47:2001;265-267.
2. Sagnella G.A. Measurement and importance of plasma brain natriuretic peptide and related peptides. Ann. Clin. Biochem. 38:2001;83-93.
3. Kelly R., Struthers A.D. Are natriuretic peptides clinically useful as markers of heart failure? Ann. Clin. Biochem. 38:2001;94-102.
4. Mair J. Role of cardiac natriuretic peptide testing in heart failure. Clin. Chem. 48:2002;977-978.
5. Stein B.C., Levin R.I. Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am. Heart J. 135:1998;914-923.
6. Clerico A., Del Ry S., Giannessi D. Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptide) in clinical practice: the need for a new generation of immunoassay methods. Clin. Chem. 46:2000;1529-1534.
7. Hunt P.J., Richards A.M., Nicholls M.G., Yandle T.G., Doughty R.N., Espiner E.A. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin. Endocrinol. 47:1997;287-296.
8. Hammerer-Lercher A., Neubauer E., Muller S., Pachinger O., Puschendorf B., Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin. Chim. Acta. 310:2001;193-197.
9. Qi W., Mathisen P., Kjekshus J., Simonsen S., Bjornerheim R., Endresen K.et al. Natriuretic peptides in patients with aortic stenosis. Am. Heart J. 142:2001;725-732.
10. Richards A.M., Nicholls M.G., Yandle T.G.et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation. 97:1998;1921-1929.
11. Fischer Y., Filzmaier K., Stiegler H.et al. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin. Chem. 47:2001;591-594.
12. Masson S., Vago T., Baldi G.et al. Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Clin. Chem. Lab. Med. 40:2002;761-763.
13. Hunt S.A., Baker D.W., Chin M.H.et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 104:2001;2996-3007.
14. Mueller T., Gegenhuber A., Poelz W., Haltmayer M. Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease. Clin. Chem. 49:2003;976-979.
15. Remme W.J., Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 22:2001;1527-1560.
16. Missbichler A., Hawa G., Schmal N., Woloszczuk W. Sandwich ELISA for proANP 1-98 facilitates investigation of left ventricular dysfunction. Eur. J. Med. Res. 6:2001;105-111.
17. Cockgroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41.
18. Hanley J.A., McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 148:1983;839-843.
19. Clerico A., Del Ry S., Maffei S., Prontera C., Emdin M., Giannessi D. The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Clin. Chem. Lab. Med. 40:2002;371-377.
20. Maisel A.S., Krishnaswamy P., Nowak R.M.et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 347:2002;161-167.
21. McCullough P.A., Nowak R.M., McCord J.et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from breathing not properly (BNP) multinational study. Circulation. 106:2002;416-422.
22. Hobbs F.D., Davis R.C., Roalfe A.K., Hare R., Davies M.K., Kenkre J.E. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ. 324:2002;1498.
23. Mair J., Friedl W., Thomas S., Puschendorf B. Natriuretic peptides in assessment of left-ventricular dysfunction. Scand. J. Clin. Lab. Invest. 59:1999;132-142.
24. Maisel A.S., Koon J., Krishnaswamy P.et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am. Heart J. 141:2001;367-374.